Loading organizations...
Loading organizations...
Biotech company focusing on oncology and multidrug-resistant infections.
Asieris Pharmaceuticals has raised $120.9M across 2 funding rounds.
Asieris Pharmaceuticals has raised $120.9M in total across 2 funding rounds.
Asieris Pharmaceuticals has raised $120.9M in total across 2 funding rounds.
Asieris Pharmaceuticals's investors include Qiming Venture Partners, Zhihua Yu.
Asieris Pharmaceuticals has raised $120.9M across 2 funding rounds. Most recently, it raised $105.9M Series D in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 11, 2020 | $105.9M Series D | Qiming Venture Partners | |
| Dec 28, 2017 | $15.0M Series B | Zhihua Yu |